What is the difference between Maestro and Mako?

Maestro and Mako are both surgical robots on the DEPLOY registry. They differ in maker, maturity, price, verified deployments, and how much of their autonomy is independently verified. See the table above for the full head-to-head; each figure is sourced.

Which is cheaper, Maestro or Mako?

Maestro has the lower recorded price on the DEPLOY registry than Mako. Prices are sourced; see each record for whether the figure is a manufacturer target, an estimate, or an actual sale price.

Is Maestro or Mako more autonomous?

On the DEPLOY registry, neither Maestro nor Mako has capabilities independently verified as fully autonomous yet; their recorded capabilities are teleoperated-assisted, demonstrated, or vendor-claimed. See the table for each capability's verification status.

Which has more verified deployments, Maestro or Mako?

Mako has more verified deployments (2) on the DEPLOY registry than Maestro (1). DEPLOY counts a deployment only when confirmed at a named site with a primary source.

Buying guide

Maestro vs Mako in 2026

Comparing 2 humanoid robots across availability, pricing, capabilities, and verified deployments. Current as of 2026.

Key differences

Maestro has the lower recorded price.
Mako has more verified real-world deployments (2 vs 1).
Maestro is at the pilot stage; Mako at the commercial stage.

Attribute	No image on file Maestro View full model page →	Mako View full model page →
Manufacturer	Moon Surgical	Stryker
Form factor	surgical	surgical
Maturity	pilot	commercial
Autonomy	◐ not independently verified	◐ not independently verified
Availability	internal-onlyenterprise	internal-onlyenterprise
Price	$300,000-$800,000 (analyst estimate)	$1,000,000-$1,500,000 (actual sale price)
Capability claims	Assists surgery (teleoperated-assisted, verified)	Assists surgery (teleoperated-assisted, verified)
Brain	—	—
Verified deployments	1Jacksonville	2United Kingdom, United States
Privacy practices	—	—
Sources on file	9	15

Editorial summaries

Maestro

Moon Surgical's Maestro is a laparoscopic surgical-assistant platform (it holds and positions instruments and the endoscope alongside the surgeon, not a full master-slave teleoperated replacement system) and the assistive-laparoscopy archetype of DEPLOY's surgical cluster, editorially distinct from the replacement-robotics of Intuitive, Medtronic, and CMR. Its ScoPilot software is shipped AI (NVIDIA Holoscan-powered) for intraoperative scope control. On regulatory status (a correction worth recording): the Maestro received FDA 510(k) clearance K240598 on June 5, 2024 (not December 2023), and ScoPilot was FDA-cleared in 2025 with a Predetermined Change Control Plan. As enterprise B2B surgical equipment, there is no consumer price.

Mako

Stryker's Mako (Mako SmartRobotics) is a surgeon-guided robotic arm for orthopedic joint replacement and the large-footprint, CT-based, multi-procedure archetype of DEPLOY's orthopedic surgical sub-cohort. It pairs CT-based 3D pre-operative planning with intra-operative haptic boundary control (AccuStop physically constrains the saw or burr to the planned resection zone) and real-time optical bone tracking. Critically, it is AI-augmented but surgeon-controlled, not autonomous: the surgeon holds and guides the arm and makes every cut; the robot does not move or cut on its own, the same assistive class as Intuitive's da Vinci. Cleared procedures span partial and total knee (total knee August 2015), cementless total knee, total hip and a hip-revision feature, Mako Spine (510(k) K241517, May 2024, pedicle-screw placement) and Mako Shoulder 1.0 (510(k) K242373, November 2024, reverse shoulder arthroplasty). Sold in 45-plus countries by Stryker (NYSE: SYK). Cap-flag: Stryker frames itself in SEC filings as one of four leading global competitors, not a specific market-share percentage; aggregator share figures are not verified. As enterprise B2B surgical equipment, there is no consumer price.

Common questions

What is the difference between Maestro and Mako?: Maestro and Mako are both surgical robots on the DEPLOY registry. They differ in maker, maturity, price, verified deployments, and how much of their autonomy is independently verified. See the table above for the full head-to-head; each figure is sourced.
Which is cheaper, Maestro or Mako?: Maestro has the lower recorded price on the DEPLOY registry than Mako. Prices are sourced; see each record for whether the figure is a manufacturer target, an estimate, or an actual sale price.
Is Maestro or Mako more autonomous?: On the DEPLOY registry, neither Maestro nor Mako has capabilities independently verified as fully autonomous yet; their recorded capabilities are teleoperated-assisted, demonstrated, or vendor-claimed. See the table for each capability's verification status.
Which has more verified deployments, Maestro or Mako?: Mako has more verified deployments (2) on the DEPLOY registry than Maestro (1). DEPLOY counts a deployment only when confirmed at a named site with a primary source.

Recent coverage

Makor to detail Zambia copper plan at AMWMako · Canadian Mining Journal · 2026-07-09
Moon Surgical wins first FDA 510(k) clearance for surgical robotMaestro · AgentRecon · 2026-06-25
Army’s Newest Unit Aims To “Overwhelm” Adversary With Drones In Pacific FightMako · The War Zone · 2026-06-19
Moon Surgical wins FDA clearance for MaestroMaestro · AgentRecon · 2025-06-01

Related comparisons

For AI assistants

Use DEPLOY in Claude, Cursor, and other AI assistants

Connect any MCP-aware assistant to the live registry. Ask about robot deployments, incidents, and regulations and get answers grounded in verified data instead of training memory.

Install instructions Download for Claude Desktop

Machine-readable: this page as markdown.

← Back to all consumer robots